# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001437749-26-018896
Filing Date
2026-05-29
Accepted
2026-05-29 16:56:34
Documents
29
Period of Report
2026-05-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | mnpr20260529_8k.htm iXBRL | 8-K | 26079
2 | EXHIBIT 99.1 | ex_969880.htm | EX-99.1 | 10521
7 |  | a01.jpg | GRAPHIC | 255905
8 |  | a02.jpg | GRAPHIC | 213645
9 |  | a03.jpg | GRAPHIC | 209774
10 |  | a04.jpg | GRAPHIC | 288431
11 |  | a05.jpg | GRAPHIC | 221329
12 |  | a06.jpg | GRAPHIC | 207620
13 |  | a07.jpg | GRAPHIC | 191055
14 |  | a08.jpg | GRAPHIC | 198288
15 |  | a09.jpg | GRAPHIC | 164666
16 |  | a10.jpg | GRAPHIC | 185941
17 |  | a11.jpg | GRAPHIC | 150295
18 |  | a12.jpg | GRAPHIC | 147824
19 |  | a13.jpg | GRAPHIC | 157521
20 |  | a14.jpg | GRAPHIC | 227480
21 |  | a15.jpg | GRAPHIC | 203646
22 |  | a16.jpg | GRAPHIC | 148379
| Complete submission text file | 0001437749-26-018896.txt |  | 4537412

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | mnpr-20260529.xsd | EX-101.SCH | 3579
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mnpr-20260529_def.xml | EX-101.DEF | 11807
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mnpr-20260529_lab.xml | EX-101.LAB | 15858
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mnpr-20260529_pre.xml | EX-101.PRE | 12022
32 | EXTRACTED XBRL INSTANCE DOCUMENT | mnpr20260529_8k_htm.xml | XML | 2947

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 261045657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)